News
Guardian: US supreme court rules human genes cannot be patented | US ...
Jun 13, · Peter Meldrum, president and CEO of Myriad Genetics, said: "We believe the court appropriately upheld our claims on cDNA and underscored the patent eligibility of our method claims, ensuring ...
Myriad Genetics' (MYGN) CEO Peter Meldrum on Q Results -...
article.wn.com
Myriad Genetics (NASDAQ:MYGN) Q Earnings Call August 12, :30 pm ET Executives Scott Gleason - Peter D. Meldrum.
Peter Meldrum Joins the Endocyte Board of Directors Nasdaq:ECYT
www.globenewswire.com
Peter Meldrum Joins the Endocyte Board of Directors ... personalized therapy, today announced Peter Meldrum, president and chief executive ...
Myriad Genetics still way ahead of burgeoning competition - Modern...
www.modernhealthcare.com
Myriad Genetics, the Salt Lake City-based provider of diagnostic tests and lab services, said the company retained 92% of the lucrative laboratory testing...
sorted by relevance / date